Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 93.61 BATS BZX Real-Time Price As of 10:50am ET |  -0.31 / -0.33%Today’s Change | 88.38 Today|||52-Week Range 129.29 | -21.63% Year-to-Date |
Latest NBIX News | Press Releases
No recent news for Neurocrine Biosciences Inc.
Today’s Trading
| Previous close | 93.92 |
| Today’s open | 93.63 |
| Day’s range | 93.61 - 94.32 |
| Volume | 2,719 |
| Average volume (3 months) | 751,626 |
| Market cap | $9.0B |
Data as of 10:50am ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +70.26% |
| Earnings growth (this year) | +39.26% |
| Earnings growth (next 5 years) | +44.74% |
| Revenue growth (last year) | +31.34% |
| P/E ratio | 148.6 |
| Price/Sales | 7.93 |
| Price/Book | 5.22 |
Competitors
Data as of 10:50am ET, 06/09/2023
Financials
| Next reporting date | August 1, 2023 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $154.5M |
| Net profit margin | 10.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
